Pharmacogenomic characterization of US FDA-approved cytotoxic drugs.
Peters EJ, Motsinger-Reif A, Havener TM, Everitt L, Hardison NE, Watson VG, Wagner M, Richards KL, Province MA, McLeod HL.
Peters EJ, et al. Among authors: hardison ne.
Pharmacogenomics. 2011 Oct;12(10):1407-15. doi: 10.2217/pgs.11.92.
Pharmacogenomics. 2011.
PMID: 22008047
Free PMC article.